The Cliff That Sends India's Founders To San Francisco

India has mastered the art of launching startups. From government grants to incubator spaces and initial seed cheques, the local ecosystem provides enough support to turn a graduate-school concept into a functional business. However, a significant gap remains for founders once they move past the early stages of development. Data indicates that approximately 85 percent of seed-funded ventures in India never secure Series A financing, a phenomenon now known as the graduation cliff.

This barrier is particularly difficult for hard-science and deep-tech companies. While consumer-focused applications can often reach revenue quickly, scientific ventures require longer periods of time and more capital to reach market viability. When the domestic funding landscape lacks the volume of late-stage investment needed for these long-horizon projects, founders are forced to look elsewhere to keep their companies alive.

Anagha Rajesh, the founder of BioCompute, offers a clear case study of this reality. After successfully encoding data into bacterial DNA in a Bengaluru laboratory, she secured initial support from domestic incubators and investors. Yet, by mid-2026, she made the decision to relocate her entire operation to San Francisco. Her move is a logical response to a market constraint rather than a rejection of her home country.

For deep-tech founders, the choice is binary. They can either stay in India and face a high probability of failure due to capital exhaustion, or they can move to where the capital infrastructure matches the ambition of their research. Until the secondary and tertiary funding rounds become more available within India, this migration of talent and intellectual property to California remains an expected outcome of the current economic structure.